PROTERIZUMAB

Clinical trials for PROTERIZUMAB explained in plain language.

Never miss a new study

Get alerted when new PROTERIZUMAB trials appear

Sign up with your email to follow new studies for PROTERIZUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy aims to boost immune attack on hard-to-treat pancreatic cancer

Disease control Recruiting now

This study tests whether adding low-dose radiation and an immunotherapy drug (pultelimab) to standard treatment can help control advanced pancreatic cancer. About 10 adults who have not had prior immunotherapy will receive the combination. The goal is to see if the treatment shri…

Matched conditions: PROTERIZUMAB

Phase: PHASE1, PHASE2 • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control

Last updated May 15, 2026 11:57 UTC

PROTERIZUMAB

Get alerted when new PROTERIZUMAB trials appear

New combo therapy aims to boost immune attack on hard-to-treat pancreatic cancer